Profound Medical (TSXV:PRN; OTCQX:PRFMF) appointed Ian Heynen as SVP of sales and marketing.
Mr. Heynen brings to Profound more than 15 years of progressive leadership experience, working with medical device companies. Most recently, he was acting president, International with Hologic, having responsibility for more than $600-million in revenue across all regions outside of the U.S.
“As we continue to drive clinical adoption of TULSA-PRO in Europe, advance the technology toward successful commercialization in the U.S., and execute our commercial plans for the Sonalleve business, we are approaching an important inflection point for accelerated growth,” Dr. Arun Menawat, president and CEO, said in a statement.
“We are excited to have recruited a sales and marketing executive of Ian’s calibre to this role, and have tremendous confidence in his ability to help us maximize our platform’s full commercial potential, both in North America and internationally,” he added.
Profound is the only company to provide a therapeutics platform that provides the precision of real-time MRI combined with the safety and ablation power of directional (inside-out) and focused (outside-in) ultrasound technology for the incision-free ablation of diseased tissue.